<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:sbol="http://sbols.org/v2#" xmlns:ns0="http://purl.org/dc/terms/" xmlns:ns1="http://www.w3.org/ns/prov#" xmlns:ns2="http://wiki.synbiohub.org/wiki/Terms/synbiohub#" xmlns:ns3="http://purl.obolibrary.org/obo/" xmlns:ns4="http://purl.org/dc/elements/1.1/">
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00377_6_sequence/1">
    <sbol:displayId>sb6b00377_6_sequence</sbol:displayId>
    <sbol:elements>ttatttattctttgcgcgc</sbol:elements>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00377_6_sequence"/>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00377_2_sequence/1">
    <sbol:displayId>sb6b00377_2_sequence</sbol:displayId>
    <sbol:elements>gtgatggtgatggtga</sbol:elements>
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00377_2_sequence"/>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00377_2_comp/1">
    <sbol:displayId>sb6b00377_2_comp</sbol:displayId>
    <ns1:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00377"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00377_2_comp"/>
    <sbol:version>1</sbol:version>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00377_2_sequence/1"/>
    <ns1:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00377_3_sequence/1">
    <sbol:displayId>sb6b00377_3_sequence</sbol:displayId>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00377_3_sequence"/>
    <sbol:elements>atgaaaaagaccaaaattgttt</sbol:elements>
    <sbol:version>1</sbol:version>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00377_6_comp/1">
    <sbol:version>1</sbol:version>
    <ns1:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00377_6_comp"/>
    <ns1:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00377"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:displayId>sb6b00377_6_comp</sbol:displayId>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00377_6_sequence/1"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00377_4_sequence/1">
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:elements>ttacaggacgtgaacagatgc</sbol:elements>
    <sbol:displayId>sb6b00377_4_sequence</sbol:displayId>
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00377_4_sequence"/>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00377_1_sequence/1">
    <sbol:elements>tggcggatgagagaag</sbol:elements>
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00377_1_sequence"/>
    <sbol:displayId>sb6b00377_1_sequence</sbol:displayId>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00377_5_comp/1">
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00377_5_comp"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00377_5_sequence/1"/>
    <ns1:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00377"/>
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb6b00377_5_comp</sbol:displayId>
    <ns1:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb6b00377_5_sequence/1">
    <sbol:elements>atgagcttactcaacgtccc</sbol:elements>
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb6b00377_5_sequence</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb6b00377_5_sequence"/>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00377_3_comp/1">
    <ns1:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00377"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00377_3_comp"/>
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb6b00377_3_comp</sbol:displayId>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00377_3_sequence/1"/>
    <ns1:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00377_1_comp/1">
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <ns1:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:version>1</sbol:version>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00377_1_sequence/1"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00377_1_comp"/>
    <ns1:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00377"/>
    <sbol:displayId>sb6b00377_1_comp</sbol:displayId>
  </sbol:ComponentDefinition>
  <sbol:Collection rdf:about="http://examples.org/Collection/sb6b00377/1">
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00377_3_comp/1"/>
    <ns0:abstract>In vitro metabolic engineering is an alternative approach to cell-based biosynthesis. It offers unprecedented flexibility for the study of biochemical pathways, thus providing useful information for the rational design and assembly of reaction modules. Herein, we took the advantage of in vitro metabolic engineering to initially gain insight into the regulatory network of a reconstituted amorpha-4,11-diene (AD) synthetic pathway. Guided by lin-log approximation, we rapidly identified the hitherto unrecognized inhibition of adenosine triphosphate (ATP) on both farnesyl pyrophosphate synthase (FPPS) and amorpha-4,11-diene synthase (ADS). Furthermore, the byproduct, pyrophosphate (PPi), potently inhibits ADS, but not FPPS. To lower the inhibition, an ATP recycling system and pyrophosphatase were used and resulted in a significant (&#8764;3-fold) enhancement in the rate of AD production (&#8764;5.7 &#956;mol L&#8211;1 min&#8211;1). A coimmobilized multienzyme reaction system was then developed to recycle the enzymes. When inhibitory metabolites concentrations were reduced, the specific enzymatic yield of AD was further enhanced (&gt;6-fold). This study demonstrated that mitigating the accumulation of inhibitory metabolites can result in higher yields of AD production by in vitro multienzymatic reactions.</ns0:abstract>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00377_1_sequence/1"/>
    <ns0:created>2017-05-18</ns0:created>
    <ns2:topLevel rdf:resource="https://synbioks.org/public/ACS/sb6b00377/1"/>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00377_3_sequence/1"/>
    <ns0:dateCopyrighted>2017</ns0:dateCopyrighted>
    <sbol:displayId>sb6b00377</sbol:displayId>
    <ns2:ownedBy rdf:resource="https://synbioks.org/user/myers"/>
    <ns0:rightsHolder>American Chemical Society</ns0:rightsHolder>
    <ns3:OBI_0002110>10.1021/acssynbio.6b00377</ns3:OBI_0002110>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00377_1_comp/1"/>
    <ns4:subject>amorpha-4,11-diene</ns4:subject>
    <ns4:rights>Copyright &#169; 2017 American Chemical Society</ns4:rights>
    <ns4:type>research-article</ns4:type>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00377_2_comp/1"/>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00377_5_sequence/1"/>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00377_2_sequence/1"/>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00377_5_comp/1"/>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00377_6_comp/1"/>
    <ns0:dateAccepted>2017-05-18</ns0:dateAccepted>
    <ns0:references>Zou, R., Zhou, K., Stephanopoulos, G., Too, H. P. Combinatorial engineering of 1-deoxy-D-xylulose 5-phosphate pathway using cross-lapping in vitro assembly (CLIVA) method PLoS One 2013. 8.</ns0:references>
    <ns0:isPartOf rdf:resource="http://pubs.acs.org/journal/asbcd6"/>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb6b00377_4_comp/1"/>
    <ns0:dateSubmitted>2016-12-13</ns0:dateSubmitted>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00377_6_sequence/1"/>
    <ns4:publisher>American Chemical
Society</ns4:publisher>
    <ns0:type rdf:resource="http://purl.org/dc/dcmitype/Text"/>
    <ns4:creator>Xixian Chen</ns4:creator>
    <ns0:description>In vitro metabolic engineering is an alternative approach to cell-based biosynthesis. It offers unprecedented flexibility for the study of biochemical pathways, thus providing useful information for the rational design and assembly of reaction modules. Herein, we took the advantage of in vitro metabolic engineering to initially gain insight into the regulatory network of a reconstituted amorpha-4,11-diene (AD) synthetic pathway. Guided by lin-log approximation, we rapidly identified the hitherto unrecognized inhibition of adenosine triphosphate (ATP) on both farnesyl pyrophosphate synthase (FPPS) and amorpha-4,11-diene synthase (ADS). Furthermore, the byproduct, pyrophosphate (PPi), potently inhibits ADS, but not FPPS. To lower the inhibition, an ATP recycling system and pyrophosphatase were used and resulted in a significant (&#8764;3-fold) enhancement in the rate of AD production (&#8764;5.7 &#956;mol L&#8211;1 min&#8211;1). A coimmobilized multienzyme reaction system was then developed to recycle the enzymes. When inhibitory metabolites concentrations were reduced, the specific enzymatic yield of AD was further enhanced (&gt;6-fold). This study demonstrated that mitigating the accumulation of inhibitory metabolites can result in higher yields of AD production by in vitro multienzymatic reactions.</ns0:description>
    <ns3:OBI_0001617>28520394</ns3:OBI_0001617>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb6b00377_4_sequence/1"/>
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Collection/sb6b00377"/>
  </sbol:Collection>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb6b00377_4_comp/1">
    <sbol:version>1</sbol:version>
    <ns1:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <ns1:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.6b00377"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb6b00377_4_sequence/1"/>
    <sbol:displayId>sb6b00377_4_comp</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb6b00377_4_comp"/>
  </sbol:ComponentDefinition>
</rdf:RDF>
